Novel food: Nicotinamide riboside chloride

Commission Implementing Regulation (EU) 2022/1160 of 5 July 2022 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use and the specifications of the novel food nicotinamide riboside chloride

Update

The European Commission has extended the permitted use of the novel food nicotinamide riboside chloride to foods for special medical purposes and total diet replacement for weight control.

What is changing?

The Commission has authorised and set out conditions for use of nicotinamide riboside chloride in foods for special medical purposes and meal replacements. These conditions, including maximum levels and additional specific labelling requirements, are set out in the Annex to the Regulation.

Why?

Following an application for extension of the use of nicotinamide riboside chloride to foods for special medical purposes and meal replacements, EFSA delivered a favourable opinion regarding its safety and bio-availability when added to such foods (EFSA 2021).

Timeline

The Regulation entered into force on 25 July 2022.

What are the major implications for exporting countries?

Producers of foods for special medical purposes and meal replacements may use nicotinamide riboside chloride as a source of niacin, in accordance with the specific conditions set out in the Regulation.

Background

Nicotinamide riboside chloride was authorised for use in food supplements for the adult population, excluding pregnant and lactating women, on the EU market by Commission Implementing Regulation (EU) 2020/16.

Resources

Sources

---

---